BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Big Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2276.64 only $796.82

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,969.34
      0.35%
      US Tech 100
      20,360.00
      0.63%
      Dow Jones
      44,296.51
      0.97%
      Brent Oil
      74.37
      -0.53%
      Bitcoin
      98,522.88
      0.49%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Cytokinetics Inc (CYTK)

      7. Cytokinetics Inc (CYTK) Financials

      Cytokinetics Inc

      Cytokinetics Inc (CYTK)

      NASDAQ
      49.10
      1.43
      (3.00%)
      Closed November 22 4:00PM
      Delayed by 15 minutes
      49.10
      0.00
      ( 0.00% )
      Pre Market: 5:30AM
      Delayed by 15 minutes

      Cytokinetics Inc Financial Summary

      The current CYTK market cap is 5.79B. The company's latest EPS is USD -4.4592 and P/E is -11.01.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 867k378k1.67M835k249k
      Operating Income -122.05M-122.27M-127.42M-126.24M-130.17M
      Net Income -128.64M-129.42M-136.9M-135.64M-143.32M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 26.87M55.83M70.43M94.59M7.53M
      Operating Income -98.87M-93.94M-186.34M-324.2M-496.21M
      Net Income -121.69M-127.29M-215.34M-388.96M-526.24M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 779.9M740.61M824.32M808.08M1.52B
      Total Liabilities 1.11B1.18B1.21B1.2B1.42B
      Total Equity -333.12M-438.8M-386.32M-396.16M108.55M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 289.81M533.8M841.32M1.01B824.32M
      Total Liabilities 300.75M420.42M597.46M1.12B1.21B
      Total Equity -10.94M113.38M243.86M-107.9M-386.32M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -244.09M-340.3M-414.33M-129.51M-228.82M
      Investing 247.63M320.66M239.25M32.64M-618.91M
      Financing -1.7M52.52M221.32M103.79M924.8M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -90.91M8.94M-142.52M-299.52M-414.33M
      Investing -74.71M-196.52M-147.78M-262.13M239.25M
      Financing 159.79M234.12M319.98M516.17M221.32M

      Stats and Ratios

      Market Cap 5.79B
      Price to Earnings Ratio -11.01
      Price to Sales Ratio 769.59
      Price to Cash Ratio 51.27
      Price to Book Ratio -15
      Dividend Yield -

      Share Statistics

      Shares Outstanding 118.01M
      Average Volume (1 week) 1.77M
      Average Volume (1 Month) 1.34M
      52 Week Change 51.54%
      52 Week High 110.25
      52 Week Low 30.68
      Spread (Intraday) 11.59 (19.64%)

      Company Info

      Company Name Cytokinetics Inc
      Address 251 little falls drive
      wilmington, delaware 19808
      Website https://www.cytokinetics.com
      Industry pharmaceutical preparations (2834)